SCHEMBL6324514

SCHEMBL6324514

CC(=O)N[C@H]1[C@@H](OC(C)=O)O[C@H](CO)[C@@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ ALDH1A1 P00352 3/20 0.49
▸ POLB P06746 2/20 0.49
▸ CYP3A4 P08684 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ TLR4 O00206 5/20 0.46
▸ THRB P10828 1/20 0.45
▸ MAPK1 P28482 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ LY96 Q9Y6Y9 2/20 0.41
▸ LGALS8 O00214 1/20 0.41
▸ LGALS3 P17931 1/20 0.41
▸ LGALS4 P56470 1/20 0.41
▸ CD69 Q07108 1/20 0.41
▸ MMP9 P14780 1/20 0.40
▸ MMP12 P39900 1/20 0.40
▸ TGM2 P21980 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10687435 1.00 LMNA (0.53) LMNAKMT2AALDH1A1POLBCYP3A4
SCHEMBL6324521 1.00 LMNA (0.53) LMNAKMT2AALDH1A1POLBCYP3A4
SCHEMBL24699769 0.91 LMNA (0.48) LMNAKMT2AALDH1A1POLBCYP3A4
SCHEMBL7154645 0.88 ALDH1A1 (0.52) LMNAKMT2AALDH1A1POLBTHRB
SCHEMBL7154639 0.88 ALDH1A1 (0.52) LMNAKMT2AALDH1A1POLBTHRB
SCHEMBL8027243 0.88 ALDH1A1 (0.52) LMNAKMT2AALDH1A1POLBTHRB
SCHEMBL29556423 0.88 ALDH1A1 (0.52) LMNAKMT2AALDH1A1POLBTHRB
SCHEMBL20032351 0.88 ALDH1A1 (0.52) LMNAKMT2AALDH1A1POLBCYP3A4
SCHEMBL8023508 0.87 LMNA (0.45) LMNAKMT2AALDH1A1POLBCYP3A4
SCHEMBL8023515 0.87 LMNA (0.45) LMNAKMT2AALDH1A1POLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6858724-B2 Non-mucin type synthetic compounds or its carrier conjugated compounds KOTOBUKI PHARMACEUTICAL CO., LTD. (JP) 2005-02-22 — — US disclosed
US-20020107224-A1 Non-mucin type synthetic compounds or its carrier conjugated compounds KOTOBUKI PHARMACEUTICAL CO., LTD. (JP) 2002-08-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107224-A1 Non-mucin type synthetic compounds or its carrier conjugated compounds MUC1, FUT5, ST6GAL1 LMNA 4472/4885KMT2A 2303/4885ALDH1A1 455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback